81 Sensitization of triple-negative breast cancer to PI3K inhibition by cotargeting IGF1R

G.R. Devi, J.L. Allensworth, M. Evans, N. Ueno, D. McDonnell, F. Bertucci, S. Van Laere. Duke University, Surgery and Duke Cancer Institute, Durham NC, USA; Duke University, Surgery, Durham NC, USA; University of Texas MD Anderson, Oncology, Houston, USA; Duke University, Pharmacology, Durham NC, USA; 5 Institut Paoli-Calmettes, Oncology, Marsellie, France; General Hospital Sint-Augustinus, Oncology, Antwerp, Belgium